Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Vicriviroc in HIV-Treatment Experienced Subjects (Study P04889AM8)(COMPLETED)

This study has been completed.
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp. Identifier:
First received: May 15, 2007
Last updated: December 18, 2015
Last verified: December 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2010
  Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):